Journal article icon

Journal article

Pravastatin normalises peripheral cardiac sympathetic hyperactivity in the spontaneously hypertensive rat

Abstract:
Hypertension is associated with heightened cardiac sympathetic drive whilst statins reduce angiotensin II (ATII) signalling, superoxide anion production and increase nitric oxide bioavailability, events that can potentially reduce peripheral cardiac sympathetic neurotransmission. We therefore investigated whether pravastatin alters peripheral cardiac sympathetic control in the spontaneously hypertensive rat (SHR). SHRs (16–18 weeks) had significantly (p < 0.05) enhanced atrial 3H-norepinephrine (3H-NE) release to field stimulation compared to normotensive WKYs. 2-week pravastatin supplementation significantly reduced 3H-NE release to levels observed in the WKY. In-vivo, pravastatin lowered resting heart rate (HR) in the SHR despite not affecting arterial blood pressure or serum cholesterol. In SHR atria/right stellate ganglion preparations, the HR response to stellate stimulation (1, 3, and 5 Hz) was also significantly reduced by pravastatin whilst the HR response to exogenous NE (0.025–5 μmol) remained similar. The nitric oxide synthase (NOS) inhibitor l-NAME (1 mmol/l) increased 3H-NE release by similar amounts in atria from supplemented and non-supplemented SHRs, whilst Western blotting showed no difference in protein levels of nNOS, eNOS, guanylyl cyclase, or the NADPH oxidase subunits Gp91 and P40phox. Pravastatin significantly reduced cardiac ATII levels and angiotensin converting enzyme 1 and 2 expressions whilst protein levels of the ATII receptor (ATR1) remained unchanged in the SHR. Immunohistochemistry co-localised ATR1 with tyrosine hydroxylase positive neurons in the stellate ganglion. The ATR1 antagonist Losartan (5 μmol) equalised release of 3H-NE to comparable levels in supplemented and non-supplemented SHRs. These results suggest 2-week pravastatin treatment reduces cardiac ATII, and prevents its facilitatory effect on NE release thus normalising cardiac sympathetic hyper-responsiveness in SHRs.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1016/j.yjmcc.2010.09.025

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Physiology Anatomy & Genetics
Role:
Author


Publisher:
Elsevier
Journal:
Journal of Molecular and Cellular Cardiology More from this journal
Volume:
50
Issue:
1
Pages:
99-106
Publication date:
2010-10-08
Acceptance date:
2010-09-29
DOI:
ISSN:
0022-2828


Language:
English
Keywords:
Pubs id:
pubs:112647
UUID:
uuid:68a67c58-52d0-4a57-b161-ba4b9468f128
Local pid:
pubs:112647
Source identifiers:
112647
Deposit date:
2012-12-19

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP